Estimation of marginal structural survival models in the presence of competing risks - PowerPoint PPT Presentation

1 / 31
About This Presentation
Title:

Estimation of marginal structural survival models in the presence of competing risks

Description:

Estimation of marginal structural survival models in the presence of competing risks Maarten Bekaert and Stijn Vansteelandt Department of Applied Mathematics and ... – PowerPoint PPT presentation

Number of Views:90
Avg rating:3.0/5.0
Slides: 32
Provided by: Maart57
Category:

less

Transcript and Presenter's Notes

Title: Estimation of marginal structural survival models in the presence of competing risks


1
Estimation of marginal structural survival models
in the presence of competing risks
  • Maarten Bekaert and Stijn Vansteelandt
  • Department of Applied Mathematics and Computer
    Science, Ghent University,
  • Ghent, Belgium
  • Karl Mertens
  • Epidemiology Unit, Scientic Institute of Public
    Health, Brussels, Belgium

Case study Estimation of attributable
mortality of ventilator associated pneumonia
2
Motivation
  • Attributable mortality of ventilator associated
    pneumonia (VAP) on 30-day ICU-mortality
  • A nosocomial pneumonia associated with mechanical
    ventilation that develops within 48 hours or more
    after hospital admission
  • Controversial results in ICU-literature due to

3
Main question To what extent does pneumonia
itself, rather than underlying comorbidity,
contribute to mortality in critically ill
patients.
4
Informative censoring
  • The decision to discharge patients is closely
    related to their health status
  • Patients are typically discharged alive because
    they have a lower risk of death.
  • These patients are therefore not comparable with
    those who stayed within the hospital.
  • Competing risk analysis
  • ICU-death ? event of interest
  • Discharge from the ICU ? competing event
  • Models based on the hazard associated with the
    CIF are used in the ICU setting

5
Causal inference
  • Confounding
  • Infected and non-infected patients are not
    comparable because they differ in terms of
    factors other than their infection status

Severity of illness
Infection
Mortality
Patients severity of illness increases the risk
of VAP and the poor health conditions leading to
VAP are also indicative of an increased mortality
risk.
6
Assumption of no unmeasured confounders
Information that leads to acquiring VAP is
completely contained within the measured
confounders
Severity of illness
VAP
Mortality
No unmeasured confounding
Unmeasured confounders
7
Non causal paths between VAP and mortality
In a non-randomized setting at a single time
point, we can adjust for confounding variables by
including them in a regression model
Severity of illness
VAP
Mortality
Causal path
Unmeasured confounders
8
Time dependent confounding
  • Confounders are time-dependent
  • They are also intermediate on the causal path
    from infection to mortality because infection
    makes an increase in severity of illness more
    likely

Severity of illnesst1
Severity of illnesst
VAPt
Mortality
VAPt1
9
Time dependent confounding
  • Association between infection and mortality is
    disturbed by time-dependent confounders
  • severity of illness at time t1 is a confounder
  • ? we need to adjust

Severity of illnesst1
Severity of illnesst
VAPt
Mortality
VAPt1
10
Time dependent confounding
  • Association between infection and mortality is
    disturbed by time-dependent confounders
  • Severity of illness at time t1 may also be
    effected by the patients
  • infection status at time t (lies on the
    causal path)
  • ? we should not adjust

Severity of illnesst1
Severity of illnesst
VAPt
Mortality
VAPt1
11
Importance of modelling evolution in severity of
illness
Severity of illness
ICU admission
12
Marginal structural survival model in the
presence of competing risks
  • Notation
  • Let At and Dt be two counting processes that
    respectively indicates 1 for ICU-acquired
    infection or ICU discharge at or prior to time t
    and 0 otherwise.
  • Under infection path
    ( 0,0,0,0,1,1,1,1,1,1, ) we would infect all
    ICU-patients 5 days after admission
  • expresses the counterfactual survival
    time, which an ICU patient would, possibly
    contrary to fact, have had under a given
    infection path
  • represents the counterfactual event
    status at time t (0 still alive in ICU, 1
    dead, 2 discharged alive from ICU)
  • For an event of type k (k 1, 2) we define
  • which is equal to the time until event k
    occurs or infinity when the competing event
    occurs

13
Marginal structural survival model in the
presence of competing risks
  • The counterfactual cumulative incidence function
  • which is the probability that, under an
    infection path , an event of type k occurs at
    or before time t.
  • Discrete time setting ? pooled logistic
    regression model for the subdistribution hazard
    of death

1
1
Its a marginal model because we do not condition
on time varying confounders because they are
themselves affected by early infections !!
For patients who have not died in the ICU, ß2
describes the effect on the hazard of ICU- death
of acquiring infection on a given day t, versus
not acquiring infection up to that day.
14
Estimation principle
  • How to fit this model
  • Select those patients whose observed data are
    compatible with the given infection path
  • Perform a competing risk analysis on those data,
    using inverse probability weighting to account
    for the selective nature of that subset

15
Selection of patients compatible the infection
path no infection
ICU admission Day 1
Day 30
  • No infection
  • Patients who died or were discharged without
    infection

infection
Discharged alive
Died in ICU
16
Discharge without infection
ICU admission Day 1
Day 20
Day 30
At
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 ? ? ? ? ?
? ? ? ? ?
  • Patients who are discharged by time t stay in the
    risk set
  • Survival time of infinity (30 days)
  • We need to expand the data set
  • Several possible infection paths after discharge

infection
Discharged alive
Died in ICU
17
Discharge without infection
ICU admission Day 1
Day 20
Day 30
At
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 ? ? ? ? ?
? ? ? ? ?
Yt
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 ? ? ? ? ?
? ? ? ? ?
t
1 20 ? ? ?
? ? ? ? ? ? ?
wt
w1 w20 ? ? ?
? ? ? ? ? ? ?
Observed information
18
Discharge without infection
ICU admission Day 1
Day 20
Day 30
At
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 1
0 0 0 0 0 0 0 0 1 1
0 0 0 0 0 0 0 1 1 1
0 0 0 0 0 0 1 1 1 1
(30 - time of discharge) 1 possible infection
paths
0 0 0 0 0 1 1 1 1 1
0 0 0 0 1 1 1 1 1 1
0 0 0 1 1 1 1 1 1 1
0 0 1 1 1 1 1 1 1 1
0 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1
0 0 0 0 0 0 0 0 0 0
Yt
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0
21 30
t
1 20
wt
w20w20
w1 w20
Observed information
19
Selection of patients compatible with getting
infection on day 5
ICU admission Day 1
Day 5
Day 30
0 0 0 0 1 1
0 0 0 0 1 1
  • Infection on day 5
  • Patients who died before day 5
  • Patients who acquired infection on day 5 and died
    in the ICU within 30 days
  • Patients who were discharged after day 5 with an
    infection acquired on day 5
  • Patients who were discharged before day 5

20
Estimating equation
21
Estimating equation
Weights
  • Calculation of the patient specific time
    dependent weights
  • Estimate
    using a logistic regression
  • For patients who are discharged
    1
  • Calculate the weights as
  • where K discharge time

22
Data analysis
  • Data set
  • Data from the National Surveillance Study of
    Nosocomial Infections in ICU's (Belgium).
  • A total of 16868 ICU patients were analyzed.
  • Of the 939 (5,6) patients who acquired VAP in
    ICU and stayed more than 3 days, 186 (19,8) died
    in the ICU, as compared to 1353(8,4) deaths
    among the 15929 patients who remained VAP-free in
    ICU

23
Confounders included in the analysis
  • Baseline confounders
  • age, gender, reason for ICU admission, acute
    coronary care, multiple trauma, presence and type
    of infections upon ICU admission, prior surgery,
    baseline antibiotic use and the SAPS score
  • Time dependent confounders
  • Invasive therapeutic treatment indicators
    collected on day t
  • indicators of exposure to mechanical ventilation,
    central vascular catheter, parenteral feeding,
    presence and/or feeding through naso- or
    oro-intestinal tube, tracheotomy intubation,
    nasal intubation, oral intubation, stoma feeding
    and surgery

24
Preliminary result
  • Crude analysis
  • Ignoring informative censoring pooled logistic
    regression
  • When not take into account time dependent
    confounding, the OR associated with infection is
    equal to 0,67 with 95 CI (0,57 0,79)
  • Including time dependent confounders as
    covariates in the model the OR equals 0,75 with
    95 CI (0,63 0,89)
  • ? infected patients have a significant decreased
    mortality

25
(No Transcript)
26
Competing risk analysis ignoring time dependent
confounding
27
1. Separated analysis per potential infection path
  • We selected patients compatible with a given
    infection path
  • Analyse the data with a weighted pooled logistic
    regression model with a flexible time trend.
  • Plot the cumulative incidence function

28
(No Transcript)
29
2. Results after solving the weighted estimating
equation
  • We defined a simple model for the effect of
    infection and a quadratic time trend without
    taking into acount the baseline confounders
  • OR equals 1,15 (no estimation of SE available
    yet)
  • Still working on models with a more complex
    impact of infection

30
(No Transcript)
31
Discussion and future work
  • When ignoring the informative censoring we get
    biased results
  • In order to get insight into the problem of time
    dependent confounding we will do a competing risk
    analysis by including the confounders as time
    dependent covariates in the model
  • Work in progress
  • Calculation of sandwich estimators of the
    standard error
  • We will develop semi-parametric estimators for
    the time-evolution in severity of illness
  • Using the COSARA data set we will be able to
    account for a lot more time dependent confounders
  • Check results with simulation studies
Write a Comment
User Comments (0)
About PowerShow.com